Response assessment criteria for brain metastases: proposal from the RANO groupNancy U. Lin, Patrick Y. Wen, Daniel P. Barboriak et al.|The Lancet Oncology|2015Cited by 1.1k
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR PathwayNaifa L. Busaidy, Lillian L. Siu, Azeez Farooki et al.|Journal of Clinical Oncology|2012Cited by 231